Dr Urban Kiernan and Dr Stephen Naylor

The complexity and uniqueness of human metabolism and physiology in the past decade has been highlighted and dissected. Arguments have been made to...

By Dr Lorna C. Ewart, et al.

Changing demands in global healthcare over the past 15 years have led to greater complexity and spiralling costs in drug development. The average p...

Professor Anthony Coates and Dr Yanmin Hu

Antibiotic resistance is at a crossroad. In the world today, deaths in low income countries from Antimicrobial Resistance (AMR) are predicted to ri...

Helen Stewart-Miller and Dr Richard Massey

Mass spectrometry (MS) has long been a valuable tool for drug discovery, and steady advances in its capabilities and performance have generated pow...

By Dr Anton Fliri, et al.

Part 2: Emergent intelligence, a new paradigm for drug discovery.

By Dr Yasmina Noubia Abdiche

The innate ability of antibodies to bind their targets with high affinity and exquisite specificity is leveraged in the discovery of therapeutic an...

By Dr Frank F. Craig

Microfluidic platforms that harness picodroplet technology (picolitre volume aqueous droplets in stabilised oil emulsions) are unlocking the potent...

Dr Satnam Surae

A review of the current approaches to data management and application within the drug development and research setting, highlighting major critical...

Mary Kay Bates

Cell therapies are poised to play a pivotal role in the development of precision and personalised medicines that will transform healthcare for mill...

Additions form a key strategic resource to advise on Breath Biopsy platform, product, and study development

A consistent and reproducible model for drug development, toxicity testing and disease modelling applications

Irvine Scientific Introduces Chemically-defined Natural Killer Cell Expansion Medium for Immunotherapy & Translational Research Applications

Concept Life Sciences expands integrated drug development services through FEI registration and investment in additional ICH stability capacity

Funding will support development of a novel enzymatic process for DNA synthesis in collaboration with Durham University

NESDEP portable laboratory for pathogen detection is now being transferred for manufacture. NESDEP detects pathogens in less than 90 minutes, and ...

Dates: 5-6 June 2018
Venue: Rotterdam, The Netherlands

Dates: 20-24 June 2018
Venue: Melbourne, Australia

Dates: 9-10 October 2018
Venue: London, UK